Pharmaceutical
Medicago and GSK Announce the Approval by Health Canada of COVIFENZ®, an Adjuvanted Plant-Based COVID-19 Vaccine
A vaccine manufactured in plants and developed in Canada 24/02/2022 — QUEBEC CITY & LONDON — (BUSINESS WIRE) Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) today […]
Personalis Announces Collaboration with UC San Diego Moores Cancer Center for Clinical Genomic Testing and Research into Composite Biomarkers and Minimal Residual Disease Detection
15/02/2022 — MENLO PARK, Calif. — (BUSINESS WIRE) Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced a strategic collaboration with the Moores Cancer Center […]
Humanigen Launches Managed Access Program for Lenzilumab
10/02/2022 — BURLINGAME, Calif. & DUBLIN & LONDON — (BUSINESS WIRE) Humanigen, Inc. (Nasdaq: HGEN), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm,’ […]
Humanigen and Cenexi Announce Collaboration to Manufacture Lenzilumab in France
Cenexi to Become Preferred Drug Product Supplier for France and the European Union 09/02/2022 — BURLINGAME, Calif. & FONTENAY-SOUS-BOIS, France — (BUSINESS WIRE) Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage […]
Merz Strengthens Partnership With Start-up Vensica and Invests up to $3 million
07/02/2022 — FRANKFURT, Germany — (BUSINESS WIRE) Merz Therapeutics, a company of the Merz Group and a leader in the field of neurotoxins, is expanding its strategic partnership with Vensica […]
Agendia Study Demonstrates MammaPrint® and BluePrint® Capture Full Spectrum of Early Breast Cancer Biology, Providing Opportunity for Highly Individualized Treatment
New analysis in peer-reviewed journal Genes, Chromosomes and Cancer further establishes that MammaPrint and BluePrint both comprehensively represent and capture the 10 hallmarks of cancer in early-stage breast cancer Study […]
Agendia to Provide First Digital MammaPrint Capability to Brazil
AI solution will expand Agendia’s testing platform in the Brazilian breast cancer market Digital MammaPrint offers fast turnaround time to molecular diagnostics, delivering actionable information to physicians treating patients with […]
Agendia Partners with Illumina to Expand Genomic Testing in Breast Cancer Care
Multi-year partnership to advance the use of next-generation sequencing for decentralized oncology testing, to bring improved insights to patients with breast cancer globally 10/01/2022 — IRVINE, Calif. & AMSTERDAM — […]
Agendia Appoints Suja Chandrasekaran and Scott Mendel to Board of Directors, Strengthening Advisory Group to Support Company Momentum
06/01/2022 — IRVINE, Calif. & AMSTERDAM — (BUSINESS WIRE) Agendia, Inc., a commercial stage company focused on precision oncology for breast cancer, today announced the appointment of healthcare industry veterans […]
Medicago submits Phase 3 data to Health Canada for its plant-based COVID-19 vaccine candidate
Final portion of data submitted as part of New Drug Submission for COVID rolling review COVID-19 vaccine candidate fully developed in Canada submitted for authorization 16/12/2021 — QUEBEC CITY — […]
Personalis Launches NeXT Personal™, A Tumor-Informed Liquid Biopsy Assay for MRD and Recurrence Detection With Part-Per-Million Sensitivity
16/12/2021 — MENLO PARK, Calif. — (BUSINESS WIRE) Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the launch of NeXT Personal, a next-generation, tumor-informed liquid […]
KOREA PACK & ICPI WEEK (Int’l Cosmetic and Pharmaceutical Industry Week) 2022 to Provide O2O Service Connecting Offline Exhibition to the Online Business Platform
13/12/2021 — GOYANG, South Korea — (BUSINESS WIRE) KOREA PACK and concurrent event ICPI WEEK (Int’l Cosmetic and Pharmaceutical Industry Week) will be held as hybrid events in 2022. This […]
Agendia Spotlight Poster at SABCS 2021 Confirms Utility of BluePrint® as Biomarker Subtyping Test to Guide Neoadjuvant Chemotherapy Decisions
Additional research from the real-world FLEX Registry focuses on age effect and lymph node status for patients with breast cancer 10/12/2021 — IRVINE, Calif. & AMSTERDAM — (BUSINESS WIRE) Agendia, […]
Analysis Presented at SABCS 2021 Confirms MammaPrint® and BluePrint® Predict Outcomes Following Neoadjuvant Chemotherapy
Data signal importance of serial genomic testing in order to appropriately adjust breast cancer treatment plans 09/12/2021 — IRVINE, Calif. & AMSTERDAM — (BUSINESS WIRE) Agendia, Inc., a world leader […]
Agendia Presents Data at SABCS 2021 Showing MammaPrint® and BluePrint® More Robustly Identify Genomic Differences in HR+ HER2- Breast Cancers in Black and White Women Beyond Clinical Factors
ER+ tumors reclassified by BluePrint as Basal-type occur at a higher frequency in Black women compared to White women Understanding tumor biological differences via MammaPrint and BluePrint and will drive […]
Medicago and GSK Announce Positive Phase 3 Efficacy and Safety Results for Adjuvanted Plant-Based COVID-19 Vaccine Candidate
Primary endpoints and secondary endpoints for which data are available were met in trial dominated by COVID-19 variants Efficacy demonstrated against all variants seen in the study, including 75.3% efficacy […]
The Lancet Respiratory Medicine Publishes Peer-Reviewed Paper and Independent Expert Commentary on Positive Phase 3 Lenzilumab Results
Lenzilumab is a variant-agnostic therapeutic that targets the dysregulated host immune response, an approach which may be of greater value than targeting the virus in hospitalized patients1 Per the paper, […]
LintonPharm Announces First Patient Dosed in Phase 1 Clinical Trial of Catumaxomab for Non-Muscle-Invasive Bladder Cancer Unresponsive to Bacillus Calmette-Guerin
01/12/2021 — GUANGZHOU, China — (BUSINESS WIRE) LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell engaging bispecific antibodies for cancer immunotherapy, today […]
Personalis Announces Updates to NeXT Platform™ Incorporating Additional Key Profiling Capabilities for Advancing Oncology Biomarkers
02/11/2021 — MENLO PARK, Calif. — (BUSINESS WIRE) Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the latest expansion of the Personalis NeXT Platform® adding […]
Dexlevo Introduces the World’s First Liquid-Type PCL at the AMWC, the World’s Largest Aesthetic and Anti-Aging Congress
This marks its entry into the European market 29/10/2021 — SEOUL, South Korea — (BUSINESS WIRE) Dexlevo, which signed an MOU with Hugel, attended the 19th Aesthetic & Anti-aging Medicine […]
European Commission Selects Humanigen’s Lenzilumab as One of the 10 Most Promising Treatments for COVID-19
Ten most promising treatments for COVID-19 identified by the European Commission’s independent experts as having “the highest potential impact on the pandemic”* European Commission’s independent panel of 10 experts across […]
Kyowa Kirin International: New Real World Evidence Underlines Benefits of POTELIGEO®▼ (mogamulizumab) Treatment for Cutaneous T-cell Lymphoma (CTCL) Patients
Patients responded better to treatment with POTELIGEO in real life, compared to data from the pivotal Phase 3 MAVORIC trial1 14/10/2021 — GALASHIELS, Scotland — (BUSINESS WIRE) Kyowa Kirin International […]
Seagen Announces Last Patient Enrolled in Phase 2 MOUNTAINEER Trial Evaluating TUKYSA® (Tucatinib) Regimen in HER2-Positive Metastatic Colorectal Cancer
– Trial Designed to Support an Accelerated Approval Application in the U.S. – 28/09/2021 — BOTHELL, Wash. — (BUSINESS WIRE) Seagen Inc. (Nasdaq: SGEN) today announced it completed patient enrollment […]
Qstream Establishes Market Presence in Balkan Region with New FollowApp Partnership
27/09/2021 — BURLINGTON, Mass. — (BUSINESS WIRE) Qstream, a global leader in microlearning technology, and FollowApp, a micro-multinational agency supporting pharmaceutical companies, today announced they have partnered to bring Qstream’s […]
Argenta Acquires Top Clinical Research Organization Klifovet to Enhance Services and Expand Global Footprint
16/09/2021 — AUCKLAND & MUNICH — (BUSINESS WIRE) Argenta, the only combined global contract research organization (CRO) and contract development & manufacturing organization (CDMO) dedicated to animal health, announced today […]
CEM Corporation & AmbioPharm Form U.S. Partnership for GMP Peptide Production
14/09/2021 — MATTHEWS, N.C. & NORTH AUGUSTA, S.C. — (BUSINESS WIRE) CEM Corporation and AmbioPharm, Inc. are excited to announce the formation of a partnership for production of GMP peptides […]
Quotient Sciences Announces Multimillion-Pound Investment in Drug Substance Manufacturing Facility
25/08/2021 — NOTTINGHAM, U.K. — (BUSINESS WIRE) Quotient Sciences, the drug development and manufacturing accelerator, announced a £6.3 million-pound investment in its recently acquired manufacturing facility in Alnwick, U.K. The […]
Merz and Israeli Start-Up Vensica Launch Partnership for Needleless Treatment of Overactive Bladder
11/08/2021 — FRANKFURT, Germany — (BUSINESS WIRE) wMerz Therapeutics, a business of the Merz Group and a leader in the field of neurotoxins, and the Israeli start-up Vensica Therapeutics Ltd., […]
Ultivue Announces Co-Marketing Agreement with Fluidigm for Biomarker Imaging Solutions for Precision Medicine
05/08/2021 — CAMBRIDGE, Mass. & SOUTH SAN FRANCISCO, Calif. — (BUSINESS WIRE) Ultivue, Inc. and Fluidigm Corporation (Nasdaq:FLDM) today announced a co-marketing agreement in which the companies will offer customers […]
Personalis, Inc. Publishes New Data Demonstrating a Novel Composite Biomarker NEOPS™ for Predicting Response to Cancer Immunotherapy in Late-Stage Melanoma Patients
02/08/2021 — MENLO PARK, Calif. — (BUSINESS WIRE) Personalis, Inc. (Nasdaq: PSNL), a leader in advanced translational genomics and diagnostics for cancer, today announced the publication of its study “Prediction […]